Pharmaceutical

ImmunoPrecise touts potential of rabbit monoclonal anti...

In an exclusive interview, the CEO of ImmunoPrecise Antibodies described the ben...

FibroBiologics and Charles River link for chronic disea...

FibroBiologics has entered a master services agreement with Charles River Labora...

FDA clamps partial hold on Phase III trial of BioNTech ...

A partial hold was placed on the trial after results showed variance between squ...

FDA approves Astellas’ VYLOY for gastric cancer treatment

Astellas Pharma has received approval from the FDA for VYLOY in conjunction with...

Cambridge University and GSK sign immunology R&D collab...

GSK has announced a £50m ($54.3m) investment in a partnership with the Universit...

Thermo Fisher’s Oncomine gains FDA approval as brain tu...

As a companion diagnostic, Oncomine will be used to identify patients eligible f...

AAO 2024: Nanoscope Therapeutics’ MCO-010 RESTOREs visi...

This trial investigated the potential of Nanoscope Therapeutics' MCO-010 to rest...

Sanofi’s $17bn sale of Opella to US investors advances ...

A stake by France-owned Bpifrance and promise of local job retention have allaye...

Health Canada approves Arcutis’ ZORYVE foam for seborrh...

Arcutis Canada, has received Health Canada's approval for ZORYVE to treat seborr...

Seaport raises $225m to advance portfolio of neuropsych...

The funding will support Seaport’s technology platform, which helps drugs be abs...

TheracosBio and BAMCO to bring BRENZAVVY to sub-Saharan...

TheracosBio has entered a partnership with BAMCO Africa to deliver BRENZAVVY (be...

Unresolved clawback issues obstruct Greece’s potential ...

A potential three-year framework agreement between the Greek government and the ...

Sanofi and Orano Med link for radioligand therapy devel...

Sanofi and Orano Group subsidiary Orano Med have announced a partnership to enha...

Opioid addiction market to reach $2.4 billion across 8M...

Late-stage pipeline products could drive combined sales of approximately $171.4 ...

US Elections: how healthcare could look under a Harris ...

With less than three weeks until Americans cast their vote, what would healthcar...

FDA approves AbbVie’s VYALEV for advanced Parkinson’s t...

The US FDA has approved AbbVie's VYALEV to treat motor fluctuations in adults wi...